News releases

News releases

May 3, 2022
COMP360 psilocybin therapy shows potential in exploratory open-label studies for anorexia nervosa and severe treatment-resistant depression
April 20, 2022
COMPASS Pathways partners with One Mind to fund Rising Star Awards for the next generation of mental health researchers
April 4, 2022
COMPASS Pathways to participate in Needham Healthcare conference
March 24, 2022
COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK
March 2, 2022
COMPASS Pathways to participate in Cowen and Roth investor conferences
February 24, 2022
COMPASS Pathways announces financial results for the fourth quarter and full year 2021 and business highlights
February 17, 2022
COMPASS Pathways plc to announce fourth quarter and full year 2021 financial results on 24 February 2022
Print page Email alerts RSS feeds
You are now leaving COMPASS Pathways’ website.

COMPASS does not control and is not responsible for the content on the website you are about to visit. COMPASS is providing this link as a convenience, and this link does not imply COMPASS endorsement of any material on the website you are about to visit. Do you wish to continue?

No Yes